Exact Sciences (EXAS) Misses Q1 EPS by 21c, Updates Guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.54), $0.21 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $707 million versus the consensus estimate of $688.78 million.
GUIDANCE:
Exact Sciences sees FY2025 revenue of $3.07-3.12 billion, versus the consensus of $3.9 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
- Dollar General stock jumps on earnings beat and raised guidance
- Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
